A nurse is assessing a client who is receiving a parental lipid infusion. Which of the following findings is a manifestation of fat overload syndrome?
Elevated temperature
Peripheral edema
Hypertension
Erythema at the insertion site
The Correct Answer is A
Fat overload syndrome is a rare but serious complication that can occur in clients receiving lipid infusion. It is typically characterized by fever.
Although spontaneous hemorrhage can occur, peripheral edema is not a typical feature of fat overload syndrome.
Hypertension is not a typical feature of fat overload syndrome. However, hypotension may occur due to fluid shift and vasodilation.
Erythema can occur at the site of infusion during lipid infusion. However, it is not a typical feature of fat overload syndrome.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Taking colchicine with food can help minimize the gastrointestinal side effects of the medication. Therefore, advising the client to take the medication with food if nausea develops is appropriate.
B. Increasing intake of grapefruit is not recommended with colchicine. Grapefruit can interact with certain medications, including colchicine, and may increase the risk of side effects.
C. Monitoring for muscle pain is not typically associated with colchicine use. Muscle pain is not a common side effect of colchicine.
D. Increased bruising is not typically associated with colchicine use. Bruising is not a common side effect of colchicine.
Correct Answer is B
Explanation
Spironolactone is a potassium-sparing diuretic used in the management of ascites associated with liver failure. Its mechanism of action includes blocking the actions of aldosterone, a hormone that promotes sodium retention and potassium excretion in the kidneys. This results in increased urinary sodium excretion and hyponatremia and hyperkalemia.
A. Decreased chloride level is not typically associated with spironolactone use.
C. Spironolactone is a potassium-sparing diuretic, so it leads to an increased potassium level (hyperkalemia)
D. Spironolactone is not associated with decreased phosphate levels.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.